13F filer · CIK 1103804 ↗

Viking Global

You are looking at Q1 2021. See the latest, Q2 2026 →

Reported value

$33.58B

−7.7% on the quarter before

Positions

94

28 new · 30 sold out

Top 10

37.1%

of the value

Est. gain

−$426.6M

on stocks held all quarter

Est. return

−1.7%

on those stocks since Q4 2020

Filed

May 17, 2021

On SEC EDGAR ↗

Positions as of Mar 31, 2021, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 64% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2020. Striped tiles are options.

Microsoft6.0%
Bridgebio Pharma Inc4.9%
Fidelity Natl Information Sv4.0%
T-Mobile Us Inc3.8%
Bk Of America Corp3.6%
Adaptive Biotechnologies Cor3.6%
Unitedhealth Group Inc3.4%
Alphabet2.8%Visa Inc.2.5%Palo Alto Networks2.4%
General Electric Co2.4%
Fortive Corp2.4%
Fleetcor Technologies Inc2.1%
Centene Corp Del2.1%
Meta2.1%
Boston Scientific Corp2.1%
Api Group Corp2.1%
Chubb Limited2.0%
Abcellera Biologics Inc1.9%
Zimmer Biomet Holdings Inc1.8%
Amazon1.7%
Oreilly Automotive Inc1.6%
Moody's Corporation1.5%
Aon Plc1.5%

Largest buys

Since Q4 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Bk Of America Corp~$1.21BNew · 0.0% → 3.6%+31,312,416 shares
  2. Oreilly Automotive Inc~$541.1MNew · 0.0% → 1.6%+1,066,676 shares
  3. Coupa Software Inc~$456.7MNew · 0.0% → 1.4%+1,794,765 shares
  4. General Electric Co~$412.9MAdded · 0.9% → 2.4%+31,449,248 shares
  5. Netflix~$391.3MNew · 0.0% → 1.2%+750,057 shares
  6. Meta~$387.8MAdded · 0.8% → 2.1%+1,316,710 shares
  7. Thermo Fisher Scientific Inc~$357.8MAdded · 0.1% → 1.2%+784,070 shares
  8. Sunrun Inc~$265.9MNew · 0.0% → 0.8%+4,396,168 shares
  9. Deere & Co~$260.6MNew · 0.0% → 0.8%+696,411 shares
  10. Laboratory Corp Amer Hldgs~$251.6MAdded · 0.1% → 0.8%+986,719 shares

Largest sells

Since Q4 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Jpmorgan Chase & Co~$1.15BCut · 3.0% → 0.4%−7,584,658 shares
  2. Microsoft~$783.2MCut · 7.2% → 6.0%−3,322,062 shares
  3. Walt Disney Company (The)~$773.9MSold out · 2.1% → 0.0%−4,271,505 shares
  4. American Express Co~$631.7MSold out · 1.7% → 0.0%−5,224,231 shares
  5. TSMC~$610.8MSold out · 1.7% → 0.0%−5,601,289 shares
  6. Hilton Worldwide Hldgs Inc~$525.1MSold out · 1.4% → 0.0%−4,719,901 shares
  7. Boston Scientific Corp~$467.5MCut · 3.0% → 2.1%−12,094,790 shares
  8. Booking Holdings Inc~$419.4MSold out · 1.2% → 0.0%−188,281 shares
  9. MercadoLibre~$368.9MCut · 1.9% → 0.7%−250,621 shares
  10. Hartford Finl Svcs Group Inc~$368.6MCut · 1.1% → 0.5%−5,518,781 shares

Holdings

As of Mar 31, 2021. Changes are in shares against Dec 31, 2020, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOM · shares −28% · price +6.0%6.0%$2.01B+$113.7M
Bridgebio Pharma IncCOM · shares 0% · price −13.4%4.9%$1.64B−$253.2M
Fidelity Natl Information SvCOM · shares −19% · price −0.6%4.0%$1.35B−$8.2M
T-Mobile Us IncCOM · shares +18% · price −7.1%3.8%$1.29B−$83.2M
Bk Of America CorpCOM · shares New3.6%$1.21B—
Adaptive Biotechnologies CorCOM · shares 0% · price −31.9%3.6%$1.21B−$566.0M
Unitedhealth Group IncCOM · shares +10% · price +6.1%3.4%$1.15B+$59.8M
AlphabetCAP STK CL A · shares −27% · price +17.7%2.8%$937.1M+$140.8M
Visa Inc.COM CL A · shares −1.2% · price −3.2%2.5%$855.1M−$28.3M
Palo Alto NetworksCOM · shares +33% · price −9.4%2.4%$807.8M−$62.9M
General Electric CoCOM · shares +108% · price +21.6%2.4%$796.3M+$68.0M
Fortive CorpCOM · shares +41% · price −0.3%2.4%$790.5M−$1.4M
Fleetcor Technologies IncCOM · shares +16% · price −1.5%2.1%$707.1M−$9.5M
Centene Corp DelCOM · shares −16% · price +6.5%2.1%$701.5M+$42.6M
MetaCL A · shares +128% · price +7.8%2.1%$691.7M+$22.1M
Boston Scientific CorpCOM · shares −40% · price +7.5%2.1%$691.7M+$48.3M
Api Group CorpCOM STK · shares 0% · price +13.9%2.1%$689.3M+$84.3M
Chubb LimitedCOM · shares +55% · price +2.6%2.0%$660.6M+$11.0M
Abcellera Biologics IncCOM · shares −1.0% · price −15.6%1.9%$648.1M−$119.8M
Zimmer Biomet Holdings IncCOM · shares −1.2% · price +3.9%1.8%$611.7M+$22.9M
AmazonCOM · shares −9.7% · price −5.0%1.7%$560.2M−$29.5M
Oreilly Automotive IncCOM · shares New1.6%$541.1M—
Moody's CorporationCOM · shares +4.3% · price +2.9%1.5%$512.4M+$13.8M
Aon PlcSHS CL A · shares −16% · price +8.9%1.5%$495.8M+$40.6M
Nuance Communications IncCOM · shares −32% · price −1.0%1.4%$483.9M−$5.0M
Total · 94 positions100%$33.58B−$426.6M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2020 to Q1 2021: 66 stocks held throughout, down $426.6M (−1.7%).

  1. Alphabet+$140.8M+18%
  2. Microsoft+$113.7M+6%
  3. Api Group Corp+$84.3M+14%
  4. Guardant Health Inc+$69.4M+18%
  5. General Electric Co+$68.0M+22%
  6. Unity Software Inc−$75.0M−35%
  7. T-Mobile Us Inc−$83.2M−7%
  8. Abcellera Biologics Inc−$119.8M−16%
  9. Bridgebio Pharma Inc−$253.2M−13%
  10. Adaptive Biotechnologies Cor−$566.0M−32%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$50.00B$25.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$35.08B−2%SEC ↗
Q1 2026$35.75B−5%SEC ↗
Q4 2025$37.68B−2%SEC ↗
Q3 2025$38.50B+11%SEC ↗
Q2 2025$34.59B+10%SEC ↗
Q1 2025$31.48B+2%SEC ↗
Q4 2024$30.90B+13%SEC ↗
Q3 2024$27.44B+5%SEC ↗
Q2 2024$26.02B−3%SEC ↗
Q1 2024$26.86B−2%SEC ↗
Q4 2023$27.30B+11%SEC ↗
Q3 2023$24.64B+1%SEC ↗
Q2 2023$24.43B+15%SEC ↗
Q1 2023$21.31B+7%SEC ↗
Q4 2022$19.98B−8%SEC ↗
Q3 2022$21.66B−1%SEC ↗
Q2 2022$21.86B−12%SEC ↗
Q1 2022$24.74B−29%SEC ↗
Q4 2021$34.71B−5%SEC ↗
Q3 2021$36.46B+11%SEC ↗
Q2 2021$32.98B−2%SEC ↗
Q1 2021$33.58B−8%SEC ↗
Q4 2020$36.37B+31%SEC ↗
Q3 2020$27.68B+20%SEC ↗
Q2 2020$23.14B+20%SEC ↗
Q1 2020$19.21B−10%SEC ↗
Q4 2019$21.35B+11%SEC ↗
Q3 2019$19.20B−14%SEC ↗
Q2 2019$22.29B+28%SEC ↗
Q1 2019$17.44B−1%SEC ↗
Q4 2018$17.57B−3%SEC ↗
Q3 2018$18.06B+3%SEC ↗
Q2 2018$17.47B+5%SEC ↗
Q1 2018$16.61B+2%SEC ↗
Q4 2017$16.26B+5%SEC ↗
Q3 2017$15.44B+4%SEC ↗
Q2 2017$14.85B−34%SEC ↗
Q1 2017$22.64B+3%SEC ↗
Q4 2016$22.01B−5%SEC ↗
Q3 2016$23.18B−2%SEC ↗
Q2 2016$23.54B+4%SEC ↗
Q1 2016$22.72BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.